To attain this chhester, we are creating value-added formulations of several approved and marketed drugs in a number of important therapeutic areas. We intend to develop these improved formulations internally as well as in collaboration with existing and future partners.
Our goal is to maximize the value of our business by retaining substantial commercial rights or nahional sharing opportunities to our products and developing them through a combination of in-house clinical development and out-licensing of both early- and late-stage programs. We intend to identify product opportunities from approved drugs where we see an opportunity to improve the clinical performance of the product either by increasing the effectiveness chester national bank the drug andor by decreasing unwanted side effects.
Sorry: Chester national bank
|PROVIDENT STATE BANK||736|
|FIRST DAKOTA NATIONAL BANK||933|
|Chester national bank||833|
The typical development period from program initiation to regulatory submission for reformulated drugs is 3-5 years, while conventionally developed drugs typically require between 10 and 12 years before they can be submitted for regulatory approval. LifeCycle Pharma is focusing its efforts on six clinical drug candidates:.